IP Library Granted Patent US 9,273,301
Granted Patent B2
US 9,273,301 · App. 14/214,834 · Granted Mar 1, 2016

Thermostable blunt-end ligase and methods of use

Inventor: Frederick Christians (Los Altos Hills, CA)
Assignee: Theranos, Inc.
C12N9/93C12P19/34C07K2319/21C07K2319/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,273,301
App. No.
14/214,834
Granted
Mar 1, 2016
Kind
B2
Abstract

Fusion proteins having thermostable blunt-end ligase activity are provided. Blunt-end ligases are useful for DNA amplification, sequencing, production of recombinant DNA and recombinant fusion proteins, and other purposes. These thermostable blunt-end DNA ligases are useful in ligation schemes which include, e.g., an incubation at about 60-65° C. or higher, or as high as about 94° C., or at other temperatures. The ligases disclosed herein may enable high temperature blunt-end ligation without need for molecular crowding agents, and so may be useful for many nucleic acid ligation-amplification schemes, e.g., ones which operate at a uniform temperature (e.g., at about 60° C. or higher), including ones which require temperature cycling, e.g., from about 94° C. to about 60° C. (or higher) for one, two, three, or more cycles. The thermostable blunt-end DNA ligases disclosed herein enable higher specificity target amplification, for example, by permitting temperature denaturation of double-stranded DNA templates as well as specific primer binding.

Claims (51)

1. A thermostable blunt-end DNA ligase suitable for use in a blunt-ended DNA ligation reaction performed at about 60° C. or higher, comprising the amino acid sequence:

(SEQ ID NO: 8)

mghhhhhhhhhhssghiegrasadgpylqileqpkqrgfrfryvcegpshg

glpgasseknkksypqvkicnyvgpakvivqlvtngknihlhahslvgkhc

edgictvtagpkdmvvgfanlgilhvtkkkvfetlearmteacirgynpgl

lvhpdlaylqaegggdrqlgdrekelirqaalqqtkemdlsvvrlmftafl

pdstgsftrrlepvvsdaiydskapnasnlkivrmdrtagcvtggeeiyll

cdkvqkddiqirfyeeeenggvwegfgdfsptdvhrqfaivfktpkykdin

itkpasvfvqlrrksdletsepkpflyypeikdkeevqrkrqkgssgtsgg

gsgggmtleearkrvnelrdliryhnyryyvladpeisdaeydrllrelke

leerfpelkspdsptlqvgarpleatfrpvrhptrmysldnafnldelkaf

eerieralgrkgpfaytvehkvdglsvnlyyeegvlvygatrgdgevgeev

tqnlltiptiprrlkgvperlevrgevympieaflrlneeleergerifkn

prnaaagslrqkdpritakrglratfyalglgleeveregvatqfallhwl

kekgfpvehgyaravgaegveavyqdwlkkrralpfeadgvvvkldelalw

relgytaraprfaiaykfpaeeketrlldvvfqvgrtgrvtpvgilepvfl

egsevsrvtlhnesyieeldirigdwvlvhkaggvipevlrvlkerrtgee

rpirwpetcpecghrllkegkvhrcpnplcpakrfeairhfasrkamdiqg

lgeklierllekglvkdvadlyrlrkedlvglermgeksaqnllrqieesk

krglerllyalglpgvgevlarnlaarfgnmdrlleasleelleveevgel

tarailetlkdpafrdlvrrlkeagvemeakekggealkgltfvitgelsr

preevkallrrlgakvtdsvsrktsylvvgenpgsklekaralgvptltee

elyrlleartgkkaeelv.

2. An article of manufacture, comprising the thermostable blunt-end DNA ligase of claim 1 and a container.

3. The article of manufacture of claim 2 , further comprising a buffer.

4. The thermostable blunt-end DNA ligase of claim 1 , wherein said thermostable blunt-end DNA ligase is suitable for use in a blunt-ended DNA ligation reaction performed at about 75° C.

5. The thermostable blunt-end DNA ligase of claim 1 , wherein said thermostable blunt-end DNA ligase is capable of making concatamers upon multiple ligation events in a blunt-ended DNA ligation reaction performed at about 60° C. or higher.

6. The thermostable blunt-end DNA ligase of claim 1 , wherein said thermostable blunt-end DNA ligase is suitable for use in a nucleic acid amplification scheme which operates at a uniform temperature of about 60° C. or higher.

7. The thermostable blunt-end DNA ligase of claim 1 , wherein said thermostable blunt-end DNA ligase is suitable for use in a nucleic acid amplification scheme which comprises temperature cycling.

8. The thermostable blunt-end DNA ligase of claim 7 , wherein said nucleic acid amplification scheme comprises temperature cycling to temperatures of about 60° C. or higher.

9. The thermostable blunt-end DNA ligase of claim 7 , wherein said nucleic acid amplification scheme comprises temperature cycling from about 94° C. to about 60° C.

10. The thermostable blunt-end DNA ligase of claim 9 , wherein said nucleic acid amplification scheme comprises two or more cycles of temperature cycling.

11. The thermostable blunt-end DNA ligase of claim 9 , wherein said nucleic acid amplification scheme comprises three or more cycles of temperature cycling.

12. The thermostable blunt-end DNA ligase of claim 1 , wherein said fusion protein comprises a component selected from a peptide linker, an N-terminal addition, a C-terminal addition, a tag peptide, a D-amino acid, and a peptide mimetic.

13. The thermostable blunt-end DNA ligase of claim 1 , wherein said fusion protein comprises a component selected from a sugar and a polymer.

14. The thermostable blunt-end DNA ligase of claim 1 , consisting of the amino acid sequence:

(SEQ ID NO: 8)

mghhhhhhhhhhssghiegrasadgpylqileqpkqrgfrfryvcegpshgglpgasseknkksypqvkicnyvgpakvivqlvtngknihlh

ahslvgkhcedgictvtagpkdmvvgfanlgilhvtkkkvfetlearmteacirgynpgllvhpdlaylqaegggdrqlgdrekelirqaalqqtke

mdlsvvrlmftaflpdstgsftrrlepvvsdaiydskapnasnlkivrmdrtagcvtggeeiyllcdkvqkddiqirfyeeeenggvwegfgdfspt

dvhrqfaivfktpkykdinitkpasvfvqlrrksdletsepkpflyypeikdkeevqrkrqkgssgtsgggsgggmtleearkrvnelrdliryhnyr

yyvladpeisdaeydrllrelkeleerfpelkspdsptlqvgarpleatfrpvrhptrmysldnafnldelkafeerieralgrkgpfaytvehkvdgls

vnlyyeegylvygatrgdgevgeevtqnlltiptiprrlkgyperlevrgevympieaflrlneeleergerifknprnaaagslrqkdpritakrglra

tfyalglgleeveregvatqfallhwlkekgfpvehgyaravgaegveavyqdwlkkrralpfeadgvvvkldelalwrelgytaraprfaiaykf

paeeketrlldvvfqvgrtgrvtpvgilepvflegsevsrvtlhnesyieeldirigdwvlvhkaggvipevlrvlkerrtgeerpirwpetcpecghrl

lkegkvhrcpnplcpakrfeairhfasrkamdiqglgekliellekglvkdvadlyrlrkedlvglermgeksaqnllrqieeskkrglerllyalgl

pgvgevlarnlaarfgnmdrlleasleelleveevgeltarailetlkdpafrdlvrrlkeagvemeakekggealkgltfvitgelsrpreevkallrrl

gakvtdsysrktsylvvgenpgsklekaralgyptlteeelyrlleartgkkaeelv.

15. The thermostable blunt-end DNA ligase of claim 1 , consisting of an amino acid having the amino acid of SEQ ID NO: 8 linked to a sugar.

16. The article of manufacture of claim 2 , wherein said container comprises a sterile access port.

17. The article of manufacture of claim 2 , wherein said thermostable blunt-end DNA ligase comprises a sugar.

Assignments (5)
CHANGE OF NAME Recorded Apr 3, 2020
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052313/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2015
From: CHRISTIANS, FREDERICK
To: THERANOS, INC.
Reel/Frame 036600/0199 →
Continuity (2)
Provisional Application 61802124 · Mar 15, 2013
Related Publication 20140273102A1 · Sep 18, 2014